RecruitingNot Applicable

Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®

Austria, Belgium, Germany450 participantsStarted 2022-04-20

Plain-language summary

Retrospective prospective Multicentric clinical follow up of patients with severe tricuspid regurgitation after being treated with the TricValve® Transcatheter Bicaval Valves System.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Successful treatment with TricValve Transcatheter Bicaval Valves System * Patient/patient's authorized legal guardian gives his consent to participate in the study and signed the corresponding inform consent Exclusion Criteria: * no exclusion criterion

What they're measuring

Number of patients with readmission for HF

Timeframe: up to 12 months

Trial details

NCT IDNCT05114850

SponsorP+F Products + Features GmbH

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-12

Contact for this trial

Sandra Scheidl, MSc

+436601148208 sscheidl@pfcardiovascular.com

View on ClinicalTrials.gov More Tricuspid Regurgitation trials